Abstract: Roots of kava (Piper methysticum) plant are used in almost all Pacific Ocean cultures to prepare a drink with sedative, anesthetic and euphoric properties. One of the main active ingredients of the extract are kava lactones. Here, kava root CO 2 extract and three kavalactones, DLkavain, dihydrokavain and yangonin (isolated from whole extract by column chromatography) were tested for their inhibitory action on recombinant homomeric human α1 glycine receptors expressed in HEK293 cells. Kava CO 2 root extract, as well as the individual components DL-kavain, dihydrokavain and yangonin inhibited glycine receptor activity in a dose-dependent manner. DL-kavain was the most potent inhibitor (IC 50 = 0.077 ± 0.002 mm), followed by yangonin (IC 50 = 0.31 ± 0.04 mm) and dihydrokavain (IC 50 = 3.23 ± 0.10 mm) which were 4-and 40-fold less active than DL-kavain, respectively. Application of kava root extract did not reduce maximum currents, but increased EC 50 of glycine. Simultaneous application of kava extract and strychnine showed additive inhibition, suggesting that binding of kavalactones and strychnine on the receptor is mutually exclusive. Overall, kavalactones exert a moderate inhibitory effect on the human α1 glycine receptor with DL-kavain being the most potent constituent.
Introduction
The inhibitory glycine receptor belongs to the Cys-loop ligand-gated ion channels and shares structural and functional similarity with other members of this superfamily, including the nicotinic acetylcholine receptor, as well as γ-aminobutyric acid (GABA A -R) and 5-HT 3 serotonin receptors (Breitinger and Becker, 2002; Thompson et al., 2010) . Glycine receptors (GlyRs) are anion selective inhibitory ligand gated ion channels that are found in the spinal cord, brain stem and higher brain centers such as the forebrain, hippocampus, hypothalamus and medial vestibular neurons as well as retina and cochlea (Breitinger and Becker, 2002; Breitinger, 2014) . GlyRs are responsible for regulating sensory stimuli and important physiological functions including muscle tone, movement and pain signaling. Cys-loop receptors are made of five homologous subunits forming the ion pore; each subunit with a distinctive N-terminal extracellular domain (ECD), a short extracellular C-terminus and four transmembrane segments (Breitinger et al., 2004; Breitinger, 2014) . Positive allosteric modulators of the inhibitory GlyR include alcohols, neurosteroids, cannabinoids, tropeines, general anaesthetics (Shan et al., 2001; Yévenes and Zeilhofer, 2011) , as well as glucose and related saccharides (Breitinger et al., 2015 . Strychnine, picrotoxin and several other alkaloids are known as glycine receptor blockers (Shan et al., 2001) . Some constituents from ginkgo biloba (used for treatment of senile dementia and benign forgetfulness) contain GlyR modulators (Ivic et al., 2003; Jaracz et al., 2004; Maleeva et al., 2015) . The search for novel GlyR modulators continues to be of great interest due to the wide distribution of GlyRs in the body and the various physiological regulatory functions controlled by glycinergic transmission (Yévenes and Zeilhofer, 2011) .
Kava kava (Piper methysticum), also known as intoxicating pepper, is a shrub commonly found in Melanesia, Micronesia and Polynesian islands . Native pacific islanders prepare a ritual, mildly intoxicating beverage from the kava root (Kubatova et al., 2001) , which is ingested to induce a relaxed psychological state during casual gatherings, ritual ceremonies, and for medicinal reasons to alter the level of consciousness . The use of kava for relief of stress and anxiety is well documented (Singh, 1983; Baum et al., 1998; Friese and Gleitz, 1998; Cass, 2004) . Phytochemically, kava root extract is composed of minor amounts of amino acids, several minerals such as aluminum, iron, calcium, magnesium, sodium and potassium in addition to three chalcones (flavokavins A, B and C) and a total of 18 kava lactones that have been identified so far . Studies made on the isolation and purification of kava concluded that kava lactones -sometimes named kavapyrones -are the major psychoactive constituents in the extract. Kava lactones are classified into substituted α-pyrones and 5,6-dihydro-α-pyrones. The latter family of compounds includes kavain, dihydrokavain, methysticin, dihydromethysticin, yangonin, desmethoxyyangonin (Kubatova et al., 2001; Sarris et al., 2011) and tetrahydroyangonin (Kubatova et al., 2001) . Kavain, dihydrokavain and methysticin are considered to be the most powerful central nervous system (CNS) active compounds (Lebot and Levesque, 1996) .
Unlike alcohol, kava was found to be non-addictive (Lebot et al., 1997; Steiner, 2000) , and unlikely to produce tolerance, withdrawal, addiction or morning-after drowsiness. In lower doses, it mostly enhances rather than impairs cognitive function (Munte et al., 1993) . Occurrence of hepatotoxic side effects has been reported (Gounder, 2006; Teschke et al., 2013) and is believed to be due to the method of extraction, the use of plant parts other than the rhizome for extraction such as peelings or aerial plant parts, wrong cultivation conditions Enna and Norton, 2012) , and use of chemical reagents instead of water or coconut milk, the traditional extraction media (Whitton et al., 2003; Sarris et al., 2011; Teschke et al., 2011) .
Numerous effects of kava constituents on neurotransmitter signaling have been reported. Kava was found to modulate functions of neuronal receptors, most prominently GABA-Rs (Jussofie et al., 1994; Yuan et al., 2002; Tawfiq et al., 2014; Chua et al., 2016; Savage et al., 2018) , as well as dopamine, histamine, opioid, and -to a lesser extent -serotonin and benzodiazepine receptors (Dinh et al., 2001; Grunze et al., 2001) . Yangonin was shown to modulate the endocannabinoid system (Ligresti et al., 2012) . Anxiolytic and sedative action (Pittler and Ernst, 2003; Sarris et al., 2013) , anesthetic (Raduege et al., 2004) and neuroprotective (Backhauss and Krieglstein, 1992; Tzeng and Lee, 2015) effects of kava have been reported. The interaction of kava constituents with other CNS drugs and receptor systems were studied (Dinh et al., 2001; Singh, 2005) , and with kava being a widely used medicinal plant, its physiological activities are monitored and reviewed regularly (Kumar, 2006; Assessment Report, 2017) .
Kava pyrones show a marked antagonistic effect upon the convulsant and lethal action of strychnine in doses up to 5 mg/kg injected in mice (Kretzschmar et al., 1970) , suggesting a possible effect of kava extract on GlyRs, although modulation of GlyR function by kava ingredients has been suggested but not shown until now (Grunze et al., 2001 ).
Here, we tested whether kavalactones isolated from kava kava (P. methysticum) might also act on glycine receptors. We describe the activity of a kava CO 2 root extract, containing 60% by weight of kavalactones, and some of its isolated constituents as inhibitors of recombinant human GlyR activity. The action of kava extract and of kavalactones DL-kavain, dihydrokavain and yangonin was tested on recombinant GlyRs using the whole-cell patch-clamp technique. DL-kavain was the most potent inhibitor of the glycine receptor. Co-inhibition of kava extract with strychnine showed simple additivity, consistent with mutually exclusive binding of both substance classes to the receptor.
Results
A 60% root extract of kava kava (P. methysticum), kindly provided by Flavex Naturextrakte (Rehlingen-Siersburg, Germany, Table 1 ) as well as three isolated kavalactones (Figure 1 ), namely DL-kavain (Sigma-Aldrich, Munich, Germany), dihydrokavain and yangonin (both isolated from the whole extract by preparative column chromatography) were tested for their action on whole-cell currents mediated by recombinant homomeric α1 glycine receptors expressed in HEK293 cells using patch-clamp electrophysiology.
Modulation of glycine receptor currents by kava extract and kavalactones
The effect of the kava lactones DL-kavain, dihydrokavain and yangonin, as well as the whole kava CO 2 root extract on homomeric α1 GlyRs expressed in HEK293 cells was examined. Glycine activated a flow of Cl − across the cell membrane, causing an inward current ( Figure 2A ). Increasing concentrations of glycine (10-1000 μm) were applied and glycine concentration-response curves were determined. Currents were normalized to the maximum response produced at saturating concentrations (1000 μm) of glycine of each cell (Figure 2A ,B).
Concentration-response data from 10 individual cells were pooled to give an averaged concentration-response curve ( Figure 3A ) with an EC 50 value of 39.5 ± 2.0 μm and an average maximum current I max of 3023 ± 486 pA (Table 2) .
Glycine receptor-mediated currents ( Figure 2B ) were recorded upon application of increasing concentrations of kava extract (0.001-0.3 mg/ml) in the constant presence of 50 μm glycine which is ~EC 60 . Whole-cell currents at different concentrations of pure DL-kavain (1-200 μm), dihydrokavain (0.05-10 mm), yangonin (0.05-3 mm), as well as strychnine control (1-500 nm), were recorded in presence of 50 μm glycine. Concentration-response curves were constructed as before ( Figure 3B ). The resulting average IC 50 values were: DL-kavain (IC 50 = 77 ± 2 μm), dihydrokavain (IC 50 = 3230 ± 100 μm), yangonin (IC 50 = 310 ± 40 μm), kava root extract (IC 50 0.060 ± 0.006 mg/ml) and strychnine (47.8 ± 4.5 nm). Patch-clamp electrophysiology results are summarized in Table 2 .
To test the mode of action of kava extract, a glycine concentration-response curve was constructed in the presence of 0.06 mg/ml kava extract and compared to the control glycine data ( Figure 3A ). We observed a shift in EC 50 to larger concentrations in presence of kava extract (EC 50 = 64.5 ± 4.1 μm, n = 5) as compared to control data without extract (EC 50 = 39.5 ± 2.0 μm, n = 10) that was statistically significant p = 0.0109) . Maximum currents, on the other hand, were not altered ( Table 2 ). To test whether strychnine and kava extract target the same or different site(s) on the receptor, a control experiment was performed where a ratio method for the determination of receptor inhibition was used (Breitinger et al., 2001; Raafat et al., 2010; Breitinger, 2012) . Here, the ratio of control currents in the absence of inhibitor, I gly , divided by the current amplitudes recorded in the presence of inhibitor X, I gly,X is plotted against inhibitor concentration [X] . This results in a linear relationship for both, non-competitive and competitive inhibitors at low concentrations for a plot of gly gly, X I I vs.
[X] ( Figure 4B ).
In the case of two inhibitors targeting the same site on the receptor, one would expect an upward shift of the ratio curve with an unchanged slope. Indeed, when the inhibition curve for kava extract was determined in the absence or presence of 30 nm strychnine, the slope of both curves was the same within experimental error, with slopes of 26.5 ± 2.5 (mg/ml) −1 for kava extract alone and 29.7 ± 4.3 (mg/ml) −1 for kava extract in the presence of 30 nm strychnine. The resulting inhibition constants were K i = 0.038 ± 0.004 mg/ml for kava extract alone, and K i = 0.034 ± 0.005 mg/ml in the presence of 30 nm strychnine. In the case of two different binding sites, the slope of the line would be expected to increase. Thus, the expected ratio curve for the case of two separate, independent binding sites (equation 3, Materials and methods) was calculated using the inhibition constant of K i = 21.2 ± 2.3 nm for strychnine (Figure 2) , calculated from the IC 50 of 48.2 ± 5.0 nm and the Cheng-Prusoff correction for our experimental conditions (50 μm glycine, EC 50 = 39.5 ± 2.0 μm for glycine, Table 2 ). The simulated curve (dotted line, Figure 4B ) does not agree with the data. Indeed, the inhibition curve for kava extract in presence of strychnine was just upward shifted ( Figure 4B ). This would be expected for strychnine and kavalactones acting additively (no synergism), thus targeting the same site on the receptor.
Given a possible common binding site for strychnine and kavalactones on the receptor, a competitive mode of inhibition by kava is feasible, as the binding sites for glycine and strychnine are considered partially overlapping. The observation that EC 50 does not appear to be reduced at saturating concentration of agonist is then an important criterion and necessary but not sufficient condition for a competitive inhibition mechanism. Therefore, the results seen from the dose-response curve at high concentrations of glycine ( Figure 3A) were verified in a separate experiment. Current responses to 1 mm and 3 mm of glycine (saturation), and 0.1 mg/ml of kava extract (~IC 90 ) were recorded, showing indeed that peak currents were not reduced in the presence of kava ( Figure 4C ). Currents were normalized to I max of the glycine control to accommodate cell to cell variations of maximum currents, and the effect was reproducible (n = 3 cells per condition, Figure 4E ). The maximum current spikes were indeed true glycine-mediated currents, as is visible from an enlargement of the initial current peak (Figure 4C insert) . When glycine (1 mm) and kava extract (0.1 mg/ml) were applied for a longer time (10 s) in a separate measurement, it was apparent that kava extract increased the rate of desensitization without reducing maximum currents ( Figure 4D ).
Discussion
Kava lactones are the major psychoactive constituents in kava root extract. Here, we studied the direct Figure 3) ; number of cells (n) is indicated. Means ± SEM are given. action of kava extract and three isolated kavalactones, DL-kavain, dihydrokavain and yangonin (Figure 1 ) on recombinant human α1 glycine receptors expressed in HEK293 cells. The results from patch-clamp whole-cell current recordings (Figure 2 ) indicated that kava CO 2 root extract, DL-kavain, dihydrokavain and yangonin were all inhibitors of the receptor, reducing glycinemediated currents in a dose-dependent manner (Figures  2 and 3) .
Kava constituents are well known for their activity on central nervous signal transmission, including anxiolytic (Garrett et al., 2003; Pittler and Ernst, 2003; Sarris et al., 2013) , and neuroprotective (Backhauss and Krieglstein, 1992; Tzeng and Lee, 2015) activities. Interaction of kavalactones with neurotransmitter systems has often been demonstrated through indirect studies: DL-kavain potentiated NMDA-mediated excitotoxicity in hippocampal neurons (Mulholland and Prendergast, 2002) , kavain and dihydromethysticin modulated field potential changes in hippocampal preparations from guinea pig (Walden et al., 1997) , and kava extract and several of its constituents were shown to affect the concentration of neurotransmitters in rat brain areas (Baum et al., 1998) . A strong, but indirect evidence of action of kava constituents on GlyRs was the demonstration of antagonism of kavalactones against strychnine toxicity in mice (Kretzschmar et al., 1970) . Thus, modulatory activity of kavalactones on GlyRs would not be surprising. There are reports in the literature of a direct action of kava and its constituents on neurotransmitter receptors. Identified targets include transient receptor potential (TRP) channels (Shimoda et al., 2015) as well as vascular Ca channels (Martin et al., 2002; Hoover et al., 2006) , and sodium channels (Gleitz et al., 1996a,b) . By far the best-characterized action of kava constituents is on GABA A receptors, where positive modulation of brainstem GABAergic signaling (Yuan et al., 2002) , as well as modulation of GABA A -R binding (Jussofie et al., 1994) were reported. Co-application of kava enhanced the effects of the GABA A potentiator diazepam (Tawfiq et al., 2014) , and a detailed mechanistic studied showed the direct potentiation of GABA A receptor-mediated currents by kavain (Chua et al., 2016) , which is thus shown to be the underlying mechanism of kava potentiation of GABAergic signaling.
In our hands, DL-kavain was the most potent inhibitor of glycine receptor activity, while the IC 50 s of kava whole extract and yangonin were ~3-fold increased. Dihydrokavain was much less active, with a ~40-fold higher IC 50 as compared to kavain ( Figure 4A , Table 2 ). It may be speculated that loss of the central C7-C8 double bond of kavain and the increase in rotational freedom may be responsible for the reduced inhibitory activity of dihydrokavain. An additional -OCH 3 group at the aromatic ring, as found in yangonin seemed to reduce inhibitory potency as well. Given the high structural similarity of all kavalactones present in the whole extract, it seems likely that they all bind to the same inhibitory site on the receptor.
Our experiments covered the concentration range of 20-3000 μm for yangonin and 10-100 mg/l for whole kava extract. Plasma concentrations of yangonin and methysticin in mice were reported to be in the order of 1-10 mg/l, corresponding to 3-40 μm (Woelk, 1995) . These were achieved after ip injection of 20-100 mg/kg of the substances. For human recreational or anxiolytic use, doses of kava extract range from 50 to 300 mg, ~1-5 mg/kg, heavy users may consume up to 2500 mg/day of kava extract (see https://kava.com/kavalactones-dosage/). Thus, with all caveats of such extrapolations, we observe effects of kava on the glycine at or near physiological plasma levels of kava constituents.
Mechanisms of activation and inhibition of ligandgated ion channels are complex, as activation comprises several elementary steps (ligand binding, channel opening/closing = gating, desensitization), and each of these steps may be modulated by inhibitors or potentiators. We found that maximum currents of the glycine receptor were not affected, EC 50 was increased (shifted to the right), and receptor desensitization markedly accelerated in the presence of kava extract ( Figure 4C-E) . Different mechanisms of modulation could be considered: (i) Unchanged I max and a right-shift of the dose-response curve, as observed, is often associated with competitive inhibition. However, the observed increase of the desensitization rate is not consistent with this mechanism. (ii) Open channel block -an uncompetitive mode of inhibition -would be compatible with unchanged I max (only the open channel can be blocked), and accelerated desensitization, but not with a right-shift of the EC 50 curve, since open channel block does not alter EC 50 (Gunthorpe and Lummis, 1999) . (iii) It is feasible that unliganded receptor species have a higher affinity for kavalactones than the liganded receptor, which would result in unchanged I max and increased EC 50 . Changes in desensitization rate are not strictly required by this model, but would not argue against it, as liganded and unliganded receptor complexes may have different desensitization rates. This would be an allosteric mechanism that nevertheless shows some distinct hallmarks of competitive inhibition. An allosteric modulation of glycine receptors by kava constituents is indeed supported by the literature, as it has been noted that kavain is an allosteric potentiator of GABA A receptors (Chua et al., 2016) , likely acting similar to benzodiazepines (Tawfiq et al., 2014) . The action of kavain on the GABA A -R has been identified to be mediated through a site which is distinct from both, the agonist binding site, and the benzodiazepine site (Chua et al., 2016) .
An allosteric mode of action -mechanism (iii) as discussed -accounted for our observations. Given the similarity between GABA A and glycine receptors, presence of a distinct site for kavalactones on both receptors would not be unexpected. Kavain and other kava constituents would target allosteric sites on both receptors, being positive modulators of GABA A -R (Chua et al., 2016) , and negative modulators of glycine receptors.
Co-application of the well-established GlyR inhibitor strychnine and kava whole extract indicated only additive inhibition, but no synergy ( Figure 4B ). This would indicate mutually exclusive binding of strychnine and kavalactones to the receptor, consistent with both compounds targeting the same binding site (Breitinger et al., 2001 ), or binding of one modulator would induce a conformational change that would prevent the second one from binding.
In the literature, strychnine toxicity was reported to be alleviated by kava extract (Kretzschmar et al., 1970) , and potentiated by flavonoids (Raafat et al., 2010) , while kava extract and flavonoids both are inhibitors of the receptor. Thus, one would expect that both, kava and flavonoids would enhance strychnine toxicity. However, flavonoids act synergistically with strychnine (Raafat et al., 2010) , while kava extract did not, so the mechanism of GlyR modulation would be different for the two substance classes. Two separate physiological activities of kavalactones have to be considered: (i) inhibition of glycine receptors, and (ii) potentiation of GABA A -R signalling (Chua et al., 2016) . It is known that GABA A agonists and potentiators such as clonazepam can be used to compensate loss of function of glycine receptors in hyperekplexia (Zhou et al., 2002) . Thus, kava may increase strychnine toxicity at glycine receptors while its concomitant potentiation of compensatory GABA signaling would alleviate its overall toxicity at the same time.
Kava extract and kavalactones constitute a class of neuroactive substances with a broad spectrum of activity and several molecular targets within the CNS, which include the inhibitory glycine receptor.
Materials and methods

Materials
Kava kava extract (CO 2 extract of kava roots with a standardized content of 60% kavalactones) was kindly provided by Flavex Naturextrakte (Rehlingen-Siersburg, Germany). The extract contained six kavapyrones, namely kavain, 7,8-dihydrokavain, methysticine, 7,8-dihydromethysticine, yangonin and 1,2-desmethoxyyangonin (Table 1) . DL-kavain was purchased from Sigma-Aldrich (Deisenhofen, Germany).
Column chromatography (CC)
Column chromatography (Heftmann, 2004 ) was used to separate out individual kavalactones from the 60% root extract. A 60 cm glass column with 3 cm diameter was used, packed with 75 g of silica as stationary phase (pore size: 60 Å; particle size: 63-200 μm). Six hundred milligrams of kava CO 2 extract dissolved in acetone were adsorbed on a minimum amount of silica, placed on top of the column and eluted using hexane -isopropanol (70:30 ratio) as eluent and collecting 4-ml fractions. Column separation was repeated with a second 600 mg sample of kava extract. Fractions were combined, solvent removed in a rotavap and fractions examined by thin layer chromatography (TLC).
Thin layer chromatography (TLC)
TLC was carried out using 2.5 cm × 10 cm silica on TLC aluminum foils. Silica plates were pre-treated with in an impregnation reagent (8 g of caffeine dissolved in 200 ml of methylene chloride) and dried at room temperature for 5 min. TLC sheets were heated on a hot plate (80°C for 5 min) before application of samples (dissolved in acetone). The protocol used for TLC visualization and detection of separated compounds was adopted from the herbal medicine compendium published by the U.S. Pharmacopeial Convention (USP). Briefly, TLC plates were treated with a derivatization reagent (170 ml of ice cold methanol with 20 ml of glacial acetic acid, 10 ml sulfuric acid, and 1 ml anisaldehyde), heated at 100°C for 4 min and viewed under UV light at 366 nm and visible light (Herbal Medicines Compendium, 2015, https://hmc.usp.org/). Kavalactones were identified according to R f values and colour on the TLC plates (Lebot and Levesque, 1996; Compendium, 2015) , and structures verified by MS (not shown).
Cell culture and transfection
HEK293 cells were grown in 10 cm tissue culture Petri dishes in Eagle Minimal Essential Medium (EMEM) (Sigma-Aldrich, Munich, Germany) supplemented with 10% FBS (Invitrogen, Karlsruhe, Germany) and penicillin/streptomycin (Sigma-Aldrich, Munich, Germany) at 5% CO 2 and 37°C in a water saturated atmosphere. For electrophysiological experiments, cells were plated on poly-L lysine treated glass coverslips in 6 cm plates. Transfection was performed 1 day after cell passage using Gene Carrier (Epoch Life Science, Sugar Land, TX, USA) as transfection agent. Briefly, 1 μg of receptor DNA and 1 μg of green fluorescent protein DNA were mixed in 100 μl EMEM; in a second Eppendorf tube, 3 μl Gene Carrier was added to 100 μl EMEM, mixed and combined with the DNA solution. After 20 min incubation at room temperature, the transfection solution was added drop wise to the cells. Measurements were performed 1-3 days after transfection.
Electrophysiological recordings and data analysis
Whole-cell recording experiments were performed using a HEKA EPC10 amplifier (HEKA Electronics, Lambrecht, Germany) controlled by Pulse software (HEKA) as described before (Breitinger et al., 2018) . Briefly, recording pipettes were pulled from borosilicate glass (World Precision Instruments, Berlin, Germany) using a Sutter P-97 horizontal puller (Sutter, Novato, CA, USA). Pipettes routinely had an open tip resistance of 3-4 MΩ. Current responses were measured at room temperature (21-23°C) at a holding potential of −60 mV. Solutions were applied using an Octaflow system (NPI electronics, Tamm, Germany), where cells were bathed in a laminar flow of buffer, giving a time resolution for solution exchange and re-equilibration of about 100 ms. The external buffer consisted of 135 mm NaCl, 5.5 mm KCl, 2 mm CaCl 2 , 1.0 mm MgCl 2 and 10 mm Hepes (pH adjusted to 7.4 with NaOH); the internal buffer was 140 mm CsCl, 1.0 mm CaCl 2 , 2.0 mm MgCl 2 , 5.0 mm EGTA and 10 mm Hepes (pH adjusted to 7.2 with CsOH). All agonist-, antagonist-and kava-containing solutions were freshly prepared from stock solutions which could be kept at −20°C for several months without loss of activity. Glycine (100 mm) and strychnine
Thus, if inhibitor X is applied at a constant concentration, and the concentration of the second inhibitor, Y, is varied, one would expect an upward shift of the ratio curve with an unchanged slope. In the case of two different binding sites, the slope of the line would be expected to increase (Breitinger, 2012) .
